Advanced search
Publication Cover
Journal of Asthma Volume 47, 2010 - Issue 8
Submit an article Journal homepage
449
Views
19
CrossRef citations to date
0
Altmetric
Case Report

Measured Immunoglobulin E in Allergic Bronchopulmonary Aspergillosis Treated With Omalizumab

Robert Y. Lin Department of Medicine, St Vincent's Hospital–Manhattan–Saint Vincent's Catholic Medical Centers, New York, New York, U.S.A.; Department of Medicine, New York Medical College, New York, New York, U.S.A.Correspondence[email protected]
, M.D.,
Sonali Sethi Department of Medicine, St Vincent's Hospital–Manhattan–Saint Vincent's Catholic Medical Centers, New York, New York, U.S.A.; Department of Medicine, New York Medical College, New York, New York, U.S.A.
, M.D. &
Geeta A. Bhargave Department of Medicine, St Vincent's Hospital–Manhattan–Saint Vincent's Catholic Medical Centers, New York, New York, U.S.A.
, M.D.
Pages 942-945 | Published online: 28 Sep 2010

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

K Suresh Babu, Riccardo Polosa & Jaymin B Morjaria. (2013) Anti-IgE – emerging opportunities for Omalizumab. Expert Opinion on Biological Therapy 13:5, pages 765-777.
Read now
Jennifer Collins, Gabriele deVos, Golda Hudes & David Rosenstreich. (2012) Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab. Journal of Asthma and Allergy 5, pages 65-70.
Read now

Articles from other publishers (17)

Meiling Jin, Jo A. Douglass, J. Stuart Elborn, Ritesh Agarwal, William J. Calhoun, Slawomir Lazarewicz, Xavier Jaumont & Meng Yan. (2023) Omalizumab in Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis. The Journal of Allergy and Clinical Immunology: In Practice 11:3, pages 896-905.
Crossref
永梅 魏. (2022) Clinical Efficacy of Omalizumab in the Treatment of Allergic Pulmonary Aspergillosis: A Meta-Analysis. Advances in Clinical Medicine 12:11, pages 10480-10488.
Crossref
Isabel C. Eraso, Saveria Sangiovanni, Eliana I. Morales & Liliana Fernández-Trujillo. (2020) Use of monoclonal antibodies for allergic bronchopulmonary aspergillosis in patients with asthma and cystic fibrosis: literature review. Therapeutic Advances in Respiratory Disease 14, pages 175346662096164.
Crossref
R. Aguiar, N.P. Fernandes, A. Lopes & C. Lopes. (2017) Allergic bronchopulmonary aspergillosis treated successfully with omalizumab. Revista Portuguesa de Pneumologia (English Edition) 23:5, pages 304-306.
Crossref
Jian-Xiong Li, Li-Chao Fan, Man-Hui Li, Wei-Jun Cao & Jin-Fu Xu. (2017) Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature. Respiratory Medicine 122, pages 33-42.
Crossref
Tetsuya Homma, Masatsugu Kurokawa, Satoshi Matsukura, Munehiro Yamaguchi & Mitsuru Adachi. (2016) Anti-IgE therapy for allergic bronchopulmonary aspergillosis. Journal of Microbiology, Immunology and Infection 49:3, pages 459-463.
Crossref
Andrew C Nyborg, Anna Zacco, Rachel Ettinger, M Jack Borrok, Jie Zhu, Tom Martin, Rob Woods, Christine Kiefer, Michael A Bowen, E. Suzanne Cohen, Ronald Herbst, Herren Wu & Steven Coats. (2015) Development of an antibody that neutralizes soluble IgE and eliminates IgE expressing B cells. Cellular & Molecular Immunology 13:3, pages 391-400.
Crossref
Robert G. Hamilton. (2016) Monitoring Allergic Patients on Omalizumab with Free and Total Serum IgE Measurements. The Journal of Allergy and Clinical Immunology: In Practice 4:2, pages 366-368.
Crossref
Irina Bobolea, Consuelo Fernández Rodriguez, Rocio Diaz-Campos, Carlos Melero-Moreno & Ramón Vives-Conesa. (2016) Measuring total IgE is useful in detecting exacerbations in patients with allergic bronchopulmonary aspergillosis receiving omalizumab. The Journal of Allergy and Clinical Immunology: In Practice 4:2, pages 361-363.
Crossref
Astrid L. Voskamp, Andrew Gillman, Karen Symons, Alessandra Sandrini, Jennifer M. Rolland, Robyn E. O'Hehir & Jo A. Douglass. (2015) Clinical Efficacy and Immunologic Effects of Omalizumab in Allergic Bronchopulmonary Aspergillosis. The Journal of Allergy and Clinical Immunology: In Practice 3:2, pages 192-199.
Crossref
Bruce L. Wolf & Ashley Johnson. (2014) Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab. The Journal of Allergy and Clinical Immunology: In Practice 2:1, pages 111-113.
Crossref
R. Agarwal, A. Chakrabarti, A. Shah, D. Gupta, J. F. Meis, R. Guleria, R. Moss & D. W. Denning. (2013) Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clinical & Experimental Allergy 43:8, pages 850-873.
Crossref
Richard B. Moss. (2012) The use of biological agents for the treatment of fungal asthma and allergic bronchopulmonary aspergillosis. Annals of the New York Academy of Sciences 1272:1, pages 49-57.
Crossref
Tse Wen Chang, Jiun-Bo Chen & Chia-Yu Chu. (2012) The pharmacological mechanisms of omalizumab in patients with very high IgE levels—Clues from studies on atopic dermatitis. Dermatologica Sinica 30:4, pages 147-153.
Crossref
María del Carmen Vennera & César Picado. (2012) Patologías mediadas por la inmunoglobulina E: de la inmunoglobulina E al omalizumab. Inmunología 31:4, pages 119-126.
Crossref
Joo-Hee KimHyun Jung JinYoung-Hee Nam, Eui-Kyung HwangYoung-Min Ye & Hae-Sim Park. (2012) Clinical Features of Allergic Bronchopulmonary Aspergillosis in Korea. Allergy, Asthma & Immunology Research 4:5, pages 305.
Crossref
Ritesh Agarwal. (2011) Severe Asthma with Fungal Sensitization. Current Allergy and Asthma Reports 11:5, pages 403-413.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.